BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21909264)

  • 1. A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients.
    Byrnes EJ; Li W; Ren P; Lewit Y; Voelz K; Fraser JA; Dietrich FS; May RC; Chaturvedi S; Chaturvedi V; Heitman J
    PLoS Pathog; 2011 Sep; 7(9):e1002205. PubMed ID: 21909264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arboreal.
    Springer DJ; Billmyre RB; Filler EE; Voelz K; Pursall R; Mieczkowski PA; Larsen RA; Dietrich FS; May RC; Filler SG; Heitman J
    PLoS Pathog; 2014 Aug; 10(8):e1004285. PubMed ID: 25144534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MLST and Whole-Genome-Based Population Analysis of Cryptococcus gattii VGIII Links Clinical, Veterinary and Environmental Strains, and Reveals Divergent Serotype Specific Sub-populations and Distant Ancestors.
    Firacative C; Roe CC; Malik R; Ferreira-Paim K; Escandón P; Sykes JE; Castañón-Olivares LR; Contreras-Peres C; Samayoa B; Sorrell TC; Castañeda E; Lockhart SR; Engelthaler DM; Meyer W
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004861. PubMed ID: 27494185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population diversity and virulence characteristics of Cryptococcus neoformans/C. gattii species complexes isolated during the pre-HIV-pandemic era.
    Pharkjaksu S; Kwon-Chung KJ; Bennett JE; Ngamskulrungroj P
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008651. PubMed ID: 33017391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates.
    Lockhart SR; Iqbal N; Harris JR; Grossman NT; DeBess E; Wohrle R; Marsden-Haug N; Vugia DJ
    PLoS One; 2013; 8(9):e74737. PubMed ID: 24019979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galleria mellonella model identifies highly virulent strains among all major molecular types of Cryptococcus gattii.
    Firacative C; Duan S; Meyer W
    PLoS One; 2014; 9(8):e105076. PubMed ID: 25133687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.
    Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W
    Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional Heterogeneity of
    Farrer RA; Ford CB; Rhodes J; Delorey T; May RC; Fisher MC; Cloutman-Green E; Balloux F; Cuomo CA
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355668
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenic diversity amongst serotype C VGIII and VGIV Cryptococcus gattii isolates.
    Rodrigues J; Fonseca FL; Schneider RO; Godinho RM; Firacative C; Maszewska K; Meyer W; Schrank A; Staats C; Kmetzsch L; Vainstein MH; Rodrigues ML
    Sci Rep; 2015 Jul; 5():11717. PubMed ID: 26153364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Aller AI; Canton E; Castañón-Olivares LR; Chowdhary A; Cordoba S; Cuenca-Estrella M; Fothergill A; Fuller J; Govender N; Hagen F; Illnait-Zaragozi MT; Johnson E; Kidd S; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; St-Germain G; Trilles L; Turnidge J
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5898-906. PubMed ID: 22948877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcus gattii comparative genomics and transcriptomics: a NIH/NIAID White Paper.
    Chaturvedi V; Nierman WC
    Mycopathologia; 2012 Jun; 173(5-6):367-73. PubMed ID: 22179781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
    González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
    Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Evolution and Innovation across the Four Major Lineages of Cryptococcus gattii.
    Farrer RA; Desjardins CA; Sakthikumar S; Gujja S; Saif S; Zeng Q; Chen Y; Voelz K; Heitman J; May RC; Fisher MC; Cuomo CA
    mBio; 2015 Sep; 6(5):e00868-15. PubMed ID: 26330512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular typing of clinical and environmental isolates of Cryptococcus gattii species complex from southern California, United States.
    Hurst S; Lysen C; Cooksey G; Vugia DJ; Litvintseva AP; Lockhart SR
    Mycoses; 2019 Nov; 62(11):1029-1034. PubMed ID: 31376185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcus gattii infections.
    Chen SC; Meyer W; Sorrell TC
    Clin Microbiol Rev; 2014 Oct; 27(4):980-1024. PubMed ID: 25278580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental isolation of Cryptococcus gattii VGII from indoor dust from typical wooden houses in the deep Amazonas of the Rio Negro basin.
    Brito-Santos F; Barbosa GG; Trilles L; Nishikawa MM; Wanke B; Meyer W; Carvalho-Costa FA; Lazéra Mdos S
    PLoS One; 2015; 10(2):e0115866. PubMed ID: 25688971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic characterization of environmental isolates of Cryptococcus gattii from Puerto Rico.
    Loperena-Alvarez Y; Ren P; Li X; Schoonmaker-Bopp DJ; Ruiz A; Chaturvedi V; Rios-Velazquez C
    Mycopathologia; 2010 Oct; 170(4):279-85. PubMed ID: 20306144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997-2011.
    Lizarazo J; Escandón P; Agudelo CI; Firacative C; Meyer W; Castañeda E
    PLoS Negl Trop Dis; 2014; 8(11):e3272. PubMed ID: 25411779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility.
    Lockhart SR; Iqbal N; Bolden CB; DeBess EE; Marsden-Haug N; Worhle R; Thakur R; Harris JR;
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):144-8. PubMed ID: 22494557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcus gattii in the Age of Whole-Genome Sequencing.
    Meyer W
    mBio; 2015 Nov; 6(6):e01761-15. PubMed ID: 26578680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.